Keratoconus is a relatively common eye disease, effecting between 1 in 500 and 1 in 2000 Americans. The disease is characterized by a progressive degeneration of the cornea, the front clear window of the eye. The cornea becomes weak, thin, and irregular in shape, resulting in high levels of astigmatism that can interfere with the ability to see clearly. Often, keratoconus patients first require glasses and, as the disease progresses, contact lenses. Often, routine contact lenses do not work but specialized hybrid lenses may give patients good sight. If the condition progresses to a severe level, a corneal transplant may be required. For a deeper understanding of this condition, explore our Keratoconus Causes and Keratoconus Symptoms pages.
Corneal collagen cross-linking (CXL) strengthens the cornea by allowing it to re-form new cross-links between and within the collagen fibers. These new cross-links help strengthen the cornea, preventing further thinning and loss of vision. Many studies have shown that CXL can often prevent the need for a corneal transplant and allow patients to wear contact lenses or glasses more comfortably and safely again. CXL was first introduced in 1998 and is now performed for keratoconus patients in approximately 400 centers throughout the world. Think of the cornea like a wicker basket. In keratoconus, the weaving comes loose. CXL adds new cross-beams to lock the shape in place. Through a research study, ClearView Eye and Laser Medical Center is now able to provide this investigational treatment to our patients using this technology.
For certain keratoconus cases, Intacs™ Eye Implants offer an alternative by reshaping the cornea to reduce astigmatism and nearsightedness. This option, alongside CXL, underscores the advancements in Keratoconus Treatment available today.
For patients with moderate to advanced keratoconus who haven't found sufficient improvement with Intacs or cross-linking alone, CTAK offers a meaningful alternative. Rather than replacing the cornea, CTAK places a thin donor tissue inlay within the corneal layers to rebuild and reshape the cone from the inside. Each inlay is custom-cut by a femtosecond laser based on your individual corneal topography, making it a highly personalized approach.
In clinical trials, 95% of treated eyes gained more than two lines of vision without glasses, and the cornea showed measurable structural improvement. CTAK can often be combined with cross-linking and is generally considered a less invasive alternative to a full corneal transplant for patients who qualify.
CTAK may be an option if you have been diagnosed with keratoconus or post-LASIK ectasia, struggle with specialty contact lenses, or have been told a corneal transplant is your only remaining path. It is not appropriate for all patients, and a detailed topography evaluation with Dr. Feldman will determine whether it's a realistic option for your eyes.
If you feel like you've exhausted your options, it's worth having that conversation. The treatment landscape for keratoconus has changed, and there may be more available to you than you've been told.
Corneal collagen cross-linking (CXL) strengthens the cornea by allowing it to re-form new cross-links between and within the collagen fibers. These new cross-links help strengthen the cornea, preventing further thinning and loss of vision. Many studies have shown that CXL can often prevent the need for a corneal transplant and allow patients to wear contact lenses or glasses more comfortably and safely again. CXL was first introduced in 1998 and is now performed for keratoconus patients in approximately 400 centers throughout the world. Through a research study, ClearView Eye and Laser Medical Center is now able to provide this investigational treatment to our patients using this technology.
Keratoconus presents various challenges, from changing vision prescriptions to night-time visual distortions. Addressing symptoms early and avoiding eye rubbing are key to managing this condition effectively.
At ClearView Eye and Laser Medical Center, Dr. Sandy T. Feldman leads the charge in tailoring keratoconus treatments to each patient's unique needs, offering advanced options like CXL and Intacs™ Eye Implants. Renowned for our patient-centered approach, we pride ourselves on high satisfaction rates, reflecting the effectiveness of our personalized care. If you're navigating the challenges of keratoconus, we invite you to schedule a free consultation with our team. Discover your treatment possibilities with ClearView and embark on a journey towards improved vision.
This content serves as a general guide and should not substitute for professional medical advice. Consult with our keratoconus specialists for an individualized treatment plan.
